{
  "docId": "019de073-ceb7-7719-9dd4-8c66dbfaed37",
  "docSlug": "b2317289d3b06d938a683c10bc0d40e0",
  "documentTitle": "Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides",
  "authorId": "organicell-regenerative-medicine",
  "authorName": "Organicell Regenerative Medicine",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 4,
  "pageCount": 17,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 4,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-ceb7-7719-9dd4-8c66dbfaed37/4",
  "deckHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37",
  "deckJsonHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37.json",
  "deckAnchorHref": "/decks/019de073-ceb7-7719-9dd4-8c66dbfaed37#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.04,
        "y": 0.96
      },
      "kind": "disclaimer",
      "text": "Private And Confidential. © 2022 Organicell Regenerative Medicine, Inc. All rights reserved.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2fad37d3-8b83-4a40-baae-b7b7e8cb98ea",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.35,
        "x": 0.62,
        "y": 0.16
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a988e937-6dd6-4613-a678-236085652048",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.55,
        "x": 0.04,
        "y": 0.16
      },
      "kind": "list",
      "text": "Underknown biotech company with diversified clinical trials\nUnique product offering ready to disrupt an enormous untapped market\nNew management team with relevant domain expertise\nCurrent Accessible Capital $10MM\nLarge addressable market\nFive (5) Investigational New Drugs (IND's)\nEighteen (18) Emergency Investigational New Drug (eIND's)\nTwo (2) currently enrolling FDA-approved trials\nExpanding potential market in research with The Beauty Health Company (Nasdaq: SKIN)\nAttractive valuation relative to market size",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "868bbb98-f3fa-44e8-865f-4f2df47e0c7e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.45,
        "x": 0.04,
        "y": 0.04
      },
      "kind": "title",
      "text": "Key Investment Considerations",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "90854150-0ae2-42d5-8860-00f1de811369",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "4af01a5e-acd1-4131-81a0-cad7e3f7e0a5",
      "evidence": "list/bullet: Underknown biotech company with diversified clinical trials",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 4,
      "from": 3,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "89ac54cf-2ebf-47cf-afab-3bd5b2bbb6bf",
      "evidence": "The Key Investment Considerations and Organicell Snapshot slides imply the importance of investing in Organicell",
      "position": 0,
      "objective": "What are the consequences of not investing in Organicell?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}